293 related articles for article (PubMed ID: 32512716)
1. Exoenzyme Y Contributes to End-Organ Dysfunction Caused by
Wagener BM; Anjum N; Christiaans SC; Banks ME; Parker JC; Threet AT; Walker RR; Isbell KD; Moser SA; Stevens T; Alexeyev MF; Audia JP; Richter W; Hardy KS; Saleh LA; Morgan C; Pittet JF
Toxins (Basel); 2020 Jun; 12(6):. PubMed ID: 32512716
[No Abstract] [Full Text] [Related]
2. [Carriage of the Pseudomonas aeruginosa virulence factors and prognosis after infection].
Zhao RZ; Zheng YJ; Chen Q
Zhonghua Er Ke Za Zhi; 2012 Sep; 50(9):672-7. PubMed ID: 23158816
[TBL] [Abstract][Full Text] [Related]
3. Type III protein secretion is associated with poor clinical outcomes in patients with ventilator-associated pneumonia caused by Pseudomonas aeruginosa.
Hauser AR; Cobb E; Bodi M; Mariscal D; Vallés J; Engel JN; Rello J
Crit Care Med; 2002 Mar; 30(3):521-8. PubMed ID: 11990909
[TBL] [Abstract][Full Text] [Related]
4. Secretion of the toxin ExoU is a marker for highly virulent Pseudomonas aeruginosa isolates obtained from patients with hospital-acquired pneumonia.
Schulert GS; Feltman H; Rabin SD; Martin CG; Battle SE; Rello J; Hauser AR
J Infect Dis; 2003 Dec; 188(11):1695-706. PubMed ID: 14639541
[TBL] [Abstract][Full Text] [Related]
5. The Pseudomonas aeruginosa exoenzyme Y impairs endothelial cell proliferation and vascular repair following lung injury.
Stevens TC; Ochoa CD; Morrow KA; Robson MJ; Prasain N; Zhou C; Alvarez DF; Frank DW; Balczon R; Stevens T
Am J Physiol Lung Cell Mol Physiol; 2014 May; 306(10):L915-24. PubMed ID: 24705722
[TBL] [Abstract][Full Text] [Related]
6. Difference of Type 3 secretion system (T3SS) effector gene genotypes (exoU and exoS) and its implication to antibiotics resistances in isolates of Pseudomonas aeruginosa from chronic otitis media.
Park MH; Kim SY; Roh EY; Lee HS
Auris Nasus Larynx; 2017 Jun; 44(3):258-265. PubMed ID: 27461174
[TBL] [Abstract][Full Text] [Related]
7. Prevalence of type III secretion genes in clinical and environmental isolates of Pseudomonas aeruginosa.
Feltman H; Schulert G; Khan S; Jain M; Peterson L; Hauser AR
Microbiology (Reading); 2001 Oct; 147(Pt 10):2659-2669. PubMed ID: 11577145
[TBL] [Abstract][Full Text] [Related]
8. Risk of developing pneumonia is enhanced by the combined traits of fluoroquinolone resistance and type III secretion virulence in respiratory isolates of Pseudomonas aeruginosa.
Sullivan E; Bensman J; Lou M; Agnello M; Shriner K; Wong-Beringer A
Crit Care Med; 2014 Jan; 42(1):48-56. PubMed ID: 23963124
[TBL] [Abstract][Full Text] [Related]
9. Influence of virulence genotype and resistance profile in the mortality of Pseudomonas aeruginosa bloodstream infections.
Peña C; Cabot G; Gómez-Zorrilla S; Zamorano L; Ocampo-Sosa A; Murillas J; Almirante B; Pomar V; Aguilar M; Granados A; Calbo E; Rodríguez-Baño J; Rodríguez-López F; Tubau F; Martínez-Martínez L; Oliver A;
Clin Infect Dis; 2015 Feb; 60(4):539-48. PubMed ID: 25378459
[TBL] [Abstract][Full Text] [Related]
10. The
Munder A; Rothschuh J; Schirmer B; Klockgether J; Kaever V; Tümmler B; Seifert R; Kloth C
Open Biol; 2018 Jan; 8(1):. PubMed ID: 29386405
[TBL] [Abstract][Full Text] [Related]
11. High frequency of the exoU+/exoS+ genotype associated with multidrug-resistant "high-risk clones" of Pseudomonas aeruginosa clinical isolates from Peruvian hospitals.
Horna G; Amaro C; Palacios A; Guerra H; Ruiz J
Sci Rep; 2019 Jul; 9(1):10874. PubMed ID: 31350412
[TBL] [Abstract][Full Text] [Related]
12. Type III secretion of ExoU is critical during early Pseudomonas aeruginosa pneumonia.
Howell HA; Logan LK; Hauser AR
mBio; 2013 Mar; 4(2):e00032-13. PubMed ID: 23481600
[TBL] [Abstract][Full Text] [Related]
13. Association between Pseudomonas aeruginosa type III secretion, antibiotic resistance, and clinical outcome: a review.
Sawa T; Shimizu M; Moriyama K; Wiener-Kronish JP
Crit Care; 2014 Dec; 18(6):668. PubMed ID: 25672496
[TBL] [Abstract][Full Text] [Related]
14.
Mancl JM; Suarez C; Liang WG; Kovar DR; Tang WJ
J Biol Chem; 2020 Mar; 295(11):3506-3517. PubMed ID: 32019868
[No Abstract] [Full Text] [Related]
15. Type 3 secretion system effector genotype and secretion phenotype of longitudinally collected Pseudomonas aeruginosa isolates from young children diagnosed with cystic fibrosis following newborn screening.
Hu H; Harmer C; Anuj S; Wainwright CE; Manos J; Cheney J; Harbour C; Zablotska I; Turnbull L; Whitchurch CB; Grimwood K; Rose B;
Clin Microbiol Infect; 2013 Mar; 19(3):266-72. PubMed ID: 22329595
[TBL] [Abstract][Full Text] [Related]
16. Molecular detection of type III secretory toxins in Pseudomonas aeruginosa isolates.
Jarjees KK
Cell Mol Biol (Noisy-le-grand); 2020 Jul; 66(5):9-14. PubMed ID: 33040805
[TBL] [Abstract][Full Text] [Related]
17. The Pseudomonas aeruginosa Exoenzyme Y: A Promiscuous Nucleotidyl Cyclase Edema Factor and Virulence Determinant.
Morrow KA; Frank DW; Balczon R; Stevens T
Handb Exp Pharmacol; 2017; 238():67-85. PubMed ID: 28181005
[TBL] [Abstract][Full Text] [Related]
18. ExoU is a potent intracellular phospholipase.
Sato H; Frank DW
Mol Microbiol; 2004 Sep; 53(5):1279-90. PubMed ID: 15387809
[TBL] [Abstract][Full Text] [Related]
19. Development of loop-mediated isothermal amplification assays for genotyping of Type III Secretion System in Pseudomonas aeruginosa.
Shi H; Chen Z; Kan J
Lett Appl Microbiol; 2015 Oct; 61(4):361-6. PubMed ID: 26219625
[TBL] [Abstract][Full Text] [Related]
20. Acquisition of expression of the Pseudomonas aeruginosa ExoU cytotoxin leads to increased bacterial virulence in a murine model of acute pneumonia and systemic spread.
Allewelt M; Coleman FT; Grout M; Priebe GP; Pier GB
Infect Immun; 2000 Jul; 68(7):3998-4004. PubMed ID: 10858214
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
